Professor Bronwyn Kingwell

Professor Bronwyn Kingwell


Senior Director, Research Therapeutic Area Lead
CSL Limited
Council Member
Elected in 2015
Citation on election

Professor Bronwyn Kingwell’s fundamental and clinical research in arterial biomechanics has driven new approaches for the management of arterial diseases. She has pioneered the transition of detailed cellular and molecular studies of high-density lipoprotein (HDL) in laboratory models, in particular with regard to glucose metabolism, to a human context. This work has opened major new avenues in HDL therapeutics for treatment of diabetes. Her contributions have also influenced national and international physical activity guidelines. Professor Kingwell has been a leader in defining Australian science policy and is an active mentor.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.